Large-scale study uncovers modifiable risk factors for young-onset dementia

Researchers have identified a wide range of risk factors for young-onset dementia.

Lower Blenrep Dose More Feasible With Revlimid in Myeloma, Early Trial Suggests

A dose-finding study presented at the recent American Society of Hematology annual meeting showed deep and durable responses with belantamab mafodotin (Blenrep) plus lenalidomide (Revlimid)

December 29, 2023

FDA Advisors Say More Data Needed for RSV Vaccines in Young Kids

FDA advisors said that more data are needed to fully understand if there are broader safety concerns related to use of respiratory syncytial virus (RSV)

December 14, 2024

Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back?

The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken sandwiches and burritos to Silk Road Medical

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.